CClinicalTrials.gg
CompletedNCT03472898Updated Mar 22, 2018

Gated SPECT Abnormality With J Point Elevation

An observational study in Cardiovascular Diseases, Electrocardiogram: Electrical Alternans and Myocardial Ischemia, sponsored by Ankara Education and Research Hospital. Completed at 1 site in Turkey. Open to male participants aged 55 Years to 55 Years. Per ClinicalTrials.gov, last updated 2018-03-22.

Sponsored by Ankara Education and Research Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
1
Ages
55 Years to 55 Years
Sex
Male
01

Study summary

The investigators present an interesting co-incidence of Gated wall abnormality in the inferolateral wall in normal sestamibi myocardial perfusion images with J wave in the inferior derivations of the ECG in a patient. The subsequent coronary angiography demonstrated 80% mid right coronary artery (RCA) stenosis, which was intervened with a drug-eluting stent. The investigators conclude that even though the myocardial perfusion is normal, the association of gated wall abnormality with J wave presentation within the same location should be further evaluated.

Read the detailed description

The isolated J-point elevation considered as a type of "early repolarization" pattern (ER), is commonly been regarded as a benign finding. However, ER associations with arrhythmic sudden death from CAD or sudden cardiac death due to either idiopathic ventricular fibrillation have been shown. A recent study reported that ER especially in inferior leads, was related to worse cardiac outcomes in patients with CAD and they argue that ER in patients with CAD seems to be associated with the myocardial scar in the absence of pathologic Q waves.

Likewise, it is rare to detect clinically important gated SPECT abnormalities in normal myocardial perfusion studies with normal transient ischemic dilatation (TID) score and without any right ventricular uptake or any pulmonary uptake. Normal myocardial perfusion findings with wall motion abnormalities are frequently encountered in the interventricular septum of the patients who have previous bypass surgery or in patients with left bundle branch block (LBBB). However, the presented patient did not have the history of any intervention or LBBB. Perfusion and function discordance can be encountered in non-ischemic dilated cardiomyopathy patients; nonetheless, EF is markedly reduced in these patients.

The presented case, J point elevation in the ECG associated with relative wall motion abnormality was an important clue to determine CAD in the lack of evident perfusion defects or significant ECG findings.

The presence of wall motion abnormalities during stress study to predict CAD in patients with normal perfusion pattern, owing to balanced ischemia, was not only reported in multi-vessel disease but also in single-vessel disease without having presented the association between either regional wall motion abnormality or a localized particular ECG pattern and culprit lesion territory.

The interesting part of the presented case is, notwithstanding the myocardial perfusion pattern is normal, the abnormal gated finding with ECG changes having the concordant localization can be a significant milestone on the way to the diagnosis. To the best of investigators knowledge, the association between J point elevation and wall motion abnormality have not been described yet. Therefore, the investigators would like to draw attention to the importance of adjoining trivial ECG changes and wall motion abnormality for readers anymore.

02

Conditions studied

  • Cardiovascular Diseases
  • Electrocardiogram: Electrical Alternans
  • Myocardial Ischemia
  • Early Repolarization Syndrome
  • Left Ventricular Hypokinesia
03

Who can participate

Ages eligible
55 Years to 55 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Case Report

Inclusion criteria

  • Case Report

Exclusion criteria

Exclusion Criteria:

  • None
04

Study design

Observational model
Other
Time perspective
Other
Enrollment
1 participant (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Case Report Proposal

    Cure

    Time frame: December 2017-January 2018

06

Study locations

1 site
  • AnkaraERH
    Ankara, Altindag 06340, Turkey
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03472898
Lead sponsor
Ankara Education and Research Hospital
Responsible party
Aylin AKBULUT (University of Health Sciences Ankara Training and Research Hospital, Ankara Education and Research Hospital) — Principal investigator
First posted
Mar 21, 2018
Start date
Dec 27, 2017
Primary completion
Jan 17, 2018
Completion
Jan 17, 2018
Last update
Mar 22, 2018

Study contacts

Aylin Akbulut
study chair · Ankara Education and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion